Lung Cancers Today· @Lung_Cancers · X·· 5 hours agoScore70
Body · original
🌟 Behind the scenes at #ESMO26 with @FSkoulidis of @UTMDAnderson, who joined us for a fantastic interview on Krascendo 1!
➡️ Stay tuned for the interview and find more #ESMO2026 news here: https://buff.ly/6YOVI22
#lcsm #NSCLC #KRAS
7 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
Krascendo 3: A randomised, phase III trial in progress of divarasib vs immunotherapy or observation in patients with resected, stage II-IIIB, KRAS G12C+ non-small cell lung cancer
https://esmocongress.esmo.orgKRASCENDO-1
https://esmocongress.esmo.orgKRASCENDO-1
https://esmocongress.esmo.orgSource: Lung Cancers Today · x.com
